bibliographic entry 3667061 [be/3667061]
https://w3id.org/oc/corpus/be/3667061

is a
content
  • Fleseriu, M, Pivonello, R, Young, J, Hamrahian, AH, Molitch, ME, Shimizu, C, Tanaka, T, Shimatsu, A, White, T, Hilliard, A, Tian, C, Sauter, N, Biller, BM, Bertagna, X. Osilodrostat, a potent oral 11beta-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease, Pituitary, 2016, 19, 138, 148, DOI: 10.1007/s11102-015-0692-z, PMID: 26542280
references